Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is Bendectin a teratogen?

J F Cordero, G P Oakley, F Greenberg

    JAMA
    |June 12, 1981
    PubMed
    Summary
    This summary is machine-generated.

    This study found no overall association between Bendectin (a medication) and major birth defects. A slight association was observed for specific defects like amniotic bands with certain Bendectin formulations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impacts of trace mineral source and ancillary drench on steer performance during a 60-day backgrounding phase.

    Animal : an international journal of animal bioscience·2024
    Same author

    Syphilis: A Case in Practice.

    The Dental register·2021
    Same author

    The role of epidemiology in informing United States childhood immunization policy and practice.

    Annals of epidemiology·2020
    Same author

    Incidence and risk factors for herpes zoster following heart transplantation.

    Transplant infectious disease : an official journal of the Transplantation Society·2013
    Same author

    Population-based birth-defect and risk-factor surveillance: data from the Northern Netherlands.

    The International journal of risk & safety in medicine·2013
    Same author

    Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep.

    Journal of psychopharmacology (Oxford, England)·2009
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    Same journal

    HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

    JAMA·2026
    Same journal

    US Dietary Supplement Use Increasing, Especially in Older Adults.

    JAMA·2026
    Same journal

    Heat Stress From Climate Change Surges Globally.

    JAMA·2026
    Same journal

    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

    JAMA·2026
    See all related articles

    Area of Science:

    • Obstetrics and Gynecology
    • Teratology
    • Pediatric Epidemiology

    Background:

    • Bendectin was a widely prescribed medication for nausea during pregnancy.
    • Concerns regarding potential teratogenic effects of Bendectin led to numerous epidemiological studies.
    • Understanding the safety profile of medications during the first trimester is crucial for maternal and child health.

    Purpose of the Study:

    • To investigate the association between first-trimester Bendectin exposure and major categories of birth defects.
    • To examine potential differences in risk associated with different Bendectin formulations.
    • To assess the statistical association and potential causal relationship between Bendectin and specific birth defects.

    Main Methods:

    • Utilized data from the Metropolitan Atlanta Congenital Defects Program (1968-1978).

    Related Experiment Videos

  • Included infants with major categories of birth defects.
  • Stratified analysis based on Bendectin formulation changes in 1976.

    • Main Results:

    • No overall association was found between Bendectin exposure and major birth defect categories.
    • A statistical association was observed for amniotic bands, a subgroup of limb reductions.
    • Specific associations were noted for esophageal atresia with the three-ingredient product and encephalocele with the two-ingredient product.

    Conclusions:

    • Statistical associations do not confirm a causal relationship between Bendectin and the studied birth defects.
    • Even if causal, the implied risk associated with Bendectin exposure is extremely low (approx. 1 in 1,000 births).
    • Further research and careful interpretation of epidemiological data are essential in evaluating medication safety during pregnancy.